Suppr
超能文献

Update of the Brazilian Guideline for Familial Hypercholesterolemia - 2021.

作者信息

Izar Maria Cristina de Oliveira, Giraldez Viviane Zorzanelli Rocha, Bertolami Adriana, Santos Filho Raul Dias Dos, Lottenberg Ana Maria, Assad Marcelo Heitor Vieira, Saraiva José Francisco Kerr, Chacra Ana Paula M, Martinez Tania L R, Bahia Luciana Ribeiro, Fonseca Francisco Antonio Helfenstein, Faludi Andre Arpad, Sposito Andrei C, Chagas Antônio Carlos Palandri, Jannes Cinthia Elim, Amaral Cristiane Kovacs, Araújo Daniel Branco de, Cintra Dennys Esper, Coutinho Elaine Dos Reis, Cesena Fernando, Xavier Hermes Toros, Mota Isabela Cardoso Pimentel, Giuliano Isabela de Carlos Back, Faria Neto José Rocha, Kato Juliana Tieko, Bertolami Marcelo Chiara, Miname Marcio Hiroshi, Castelo Maria Helane Costa Gurgel, Lavrador Maria Sílvia Ferrari, Machado Roberta Marcondes, Souza Patrícia Guedes de, Alves Renato Jorge, Machado Valeria Arruda, Salgado Filho Wilson

机构信息

Universidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brasil.

Instituto do Coração (InCor) da Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP - Brasil.

出版信息

Arq Bras Cardiol. 2021 Oct;117(4):782-844. doi: 10.36660/abc.20210788.

DOI:10.36660/abc.20210788

PMID:34709306

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8528358/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8528358/93c7bca45e80/0066-782X-abc-117-04-0782-gf01.jpg

相似文献

Update of the Brazilian Guideline for Familial Hypercholesterolemia - 2021.

Arq Bras Cardiol. 2021 Oct;117(4):782-844. doi: 10.36660/abc.20210788.

[First Brazilian Guidelines for Familial Hypercholesterolemia].

Arq Bras Cardiol. 2012 Aug;99(2 Suppl 2):1-28. doi: 10.5935/abc.20120202.

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.

J Am Heart Assoc. 2019 Dec 17;8(24):e013225. doi: 10.1161/JAHA.119.013225. Epub 2019 Dec 16.

Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992.

Am J Cardiol. 1993 Sep 30;72(10):1D-84D.

Management of patients with homozygous familial hypercholesterolemia.

Am J Manag Care. 2013 Nov;19(13 Suppl):s.

Coronary Artery Calcification in Familial Hypercholesterolemia: An Opportunity for Risk Assessment and Shared Decision Making With the Power of Zero?

Circulation. 2020 Oct 13;142(15):1405-1407. doi: 10.1161/CIRCULATIONAHA.120.049057. Epub 2020 Oct 12.

The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.

Circulation. 2015 Dec 1;132(22):2167-92. doi: 10.1161/CIR.0000000000000297. Epub 2015 Oct 28.

Familial hypercholesterolemia: clues to catching it early.

J Fam Pract. 2015 Aug;64(8):464-9.

Familial hypercholesterolemia: a challenge of diagnosis and therapy.

Cleve Clin J Med. 2006 Jan;73(1):57-64. doi: 10.3949/ccjm.73.1.57.

Familial hypercholesterolemia. There is a need for early detection and treatment.

JAMA. 1987 Jan 2;257(1):69-70. doi: 10.1001/jama.257.1.69.

引用本文的文献

Single-base polymorphism of the ACE2 and TNF-alpha genes in patients with the cardiac and indeterminate forms of Chagas disease.

Braz J Infect Dis. 2025 Sep-Oct;29(5):104574. doi: 10.1016/j.bjid.2025.104574. Epub 2025 Aug 14.

An Adapted Cardioprotective Diet with or Without Phytosterol and/or Krill Oil Supplementation in Familial Hypercholesterolemia: Results of a Pilot Randomized Clinical Trial.

Nutrients. 2025 Jun 15;17(12):2008. doi: 10.3390/nu17122008.

Detecting Familial Hypercholesterolemia in Adolescents: Universal Screening is Key.

Arq Bras Cardiol. 2025 May 23;122(3):e20250178. doi: 10.36660/abc.20250178. eCollection 2025.

Cascade Screening in Adolescents with Lipid Disorders Suggestive of Familial Hypercholesterolemia: Findings from the ERICA Study in Curitiba.

Arq Bras Cardiol. 2025 Mar;122(3):e20240468. doi: 10.36660/abc.20240468.

New cardiovascular disease markers in patients with familial hypercholesterolemia carriers of genetic variants.

J Diabetes Metab Disord. 2024 Dec 16;24(1):13. doi: 10.1007/s40200-024-01537-w. eCollection 2025 Jun.

Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.

Arq Bras Cardiol. 2024 Oct 28;121(9):e20240608. doi: 10.36660/abc.20240608.

Gene Mutation in Patients with Familial Hypercholesterolemia and Response to Alirocumab Treatment-A Single-Centre Analysis.

J Clin Med. 2024 Sep 22;13(18):5615. doi: 10.3390/jcm13185615.

Methylation status of , and is associated with cardiovascular events in familial hypercholesterolemia.

Epigenomics. 2024;16(11-12):809-820. doi: 10.1080/17501911.2024.2351792. Epub 2024 Jun 17.

Prevalence and factors associated with possible cases of familial hypercholesterolemia in Brazilian adults: a cross-sectional study.

Sci Rep. 2023 Nov 22;13(1):20459. doi: 10.1038/s41598-023-47692-7.

Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.

Brain Sci. 2023 Jun 22;13(7):979. doi: 10.3390/brainsci13070979.

本文引用的文献

Clinical implications and outcomes of the ORION Phase III trials.

Future Cardiol. 2021 Aug;17(5):769-777. doi: 10.2217/fca-2020-0150. Epub 2020 Dec 21.

Evinacumab in Patients with Refractory Hypercholesterolemia.

N Engl J Med. 2020 Dec 10;383(24):2307-2319. doi: 10.1056/NEJMoa2031049. Epub 2020 Nov 15.

Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER).

J Clin Lipidol. 2020 Nov-Dec;14(6):807-817. doi: 10.1016/j.jacl.2020.08.006. Epub 2020 Aug 19.

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.

N Engl J Med. 2020 Oct 1;383(14):1317-1327. doi: 10.1056/NEJMoa2019910. Epub 2020 Aug 29.

Evinacumab for Homozygous Familial Hypercholesterolemia.

N Engl J Med. 2020 Aug 20;383(8):711-720. doi: 10.1056/NEJMoa2004215.

Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Circulation. 2020 Jun 2;141(22):1742-1759. doi: 10.1161/CIRCULATIONAHA.119.044795. Epub 2020 May 29.

Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.

J Am Coll Cardiol. 2020 May 26;75(20):2553-2566. doi: 10.1016/j.jacc.2020.03.057.

PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.

J Clin Lipidol. 2020 May-Jun;14(3):322-330.e5. doi: 10.1016/j.jacl.2020.03.001. Epub 2020 Mar 28.

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia.

N Engl J Med. 2020 Apr 16;382(16):1520-1530. doi: 10.1056/NEJMoa1913805. Epub 2020 Mar 18.

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.

J Am Coll Cardiol. 2020 Feb 18;75(6):565-574. doi: 10.1016/j.jacc.2019.12.020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Update of the Brazilian Guideline for Familial Hypercholesterolemia - 2021.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译